caa a22 4500 465789862 CHVBK 20180323112020.0 cr unu---uuuuu 170327e19901101xx s 000 0 eng 10.1007/BF00198600 doi (NATIONALLICENCE)springer-10.1007/BF00198600 Phase II study of ionidamine in patients with metastatic breast cancer [Elektronische Daten] An Eastern Cooperative Oncology Group study [H. Robins, Donna Neuberg, Al Benson III, Kishan Pandya, Douglass Tormey] Summary: The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials. Kluwer Academic Publishers, 1990 lonidamine nationallicence breast cancer nationallicence Robins H. University of Wisconsin Clinical Cancer Center, 600 Highland Avenue, 53792, Madison, WI, USA aut Neuberg Donna Dana-Farber Cancer Institute, Harvard School of Public Health, CA-23318, Boston, MA, USA aut Benson III Al Northwestern University Medical Center, Chicago, IL, USA aut Pandya Kishan University of Rochester Cancer Center, Rochester, NY, USA aut Tormey Douglass University of Wisconsin Clinical Cancer Center, 600 Highland Avenue, 53792, Madison, WI, USA aut Investigational New Drugs Kluwer Academic Publishers 8/4(1990-11-01), 397-399 0167-6997 8:4<397 1990 8 10637 https://doi.org/10.1007/BF00198600 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00198600 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Robins H. University of Wisconsin Clinical Cancer Center, 600 Highland Avenue, 53792, Madison, WI, USA aut NATIONALLICENCE 700 1- Neuberg Donna Dana-Farber Cancer Institute, Harvard School of Public Health, CA-23318, Boston, MA, USA aut NATIONALLICENCE 700 1- Benson III Al Northwestern University Medical Center, Chicago, IL, USA aut NATIONALLICENCE 700 1- Pandya Kishan University of Rochester Cancer Center, Rochester, NY, USA aut NATIONALLICENCE 700 1- Tormey Douglass University of Wisconsin Clinical Cancer Center, 600 Highland Avenue, 53792, Madison, WI, USA aut NATIONALLICENCE 773 0- Investigational New Drugs Kluwer Academic Publishers 8/4(1990-11-01), 397-399 0167-6997 8:4<397 1990 8 10637 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer